Wendy Carruthers Boston Scientific Corp (BSX) insider trading activity

Wendy Carruthers is EVP, Human Resources of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 48,348 shares of BSX, which is worth approximately $3.65 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 6,983 shares (Common Stock) at a price of $71.47 per share, resulting in proceeds of $499,075. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.3K

10.11% 3M change

38.1% 12M change

Total Value Held $3.65 Million

Wendy Carruthers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2024	SELL Open market or private sale	$499,075 $71.47 p/Share	6,983 Reduced 12.62%	48,348 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 7.15%	55,331 Common Stock
Apr 01 2024	SELL Open market or private sale	$477,776 $68.42 p/Share	6,983 Reduced 12.03%	51,068 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 6.84%	58,051 Common Stock
Mar 01 2024	SELL Open market or private sale	$463,322 $66.35 p/Share	6,983 Reduced 11.49%	53,788 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 6.56%	60,771 Common Stock
Feb 23 2024	SELL Open market or private sale	$467,092 $66.89 p/Share	6,983 Reduced 11.0%	56,508 Common Stock

Feb 23 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 6.29%	63,491 Common Stock
Feb 20 2024	SELL Bona fide gift	-	3,050 Reduced 4.9%	59,228 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$54,104 $65.82 p/Share	822 Reduced 1.3%	62,278 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	1,853 Added 2.85%	63,100 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$65,688 $65.82 p/Share	998 Reduced 1.6%	61,247 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	2,250 Added 3.49%	62,245 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$59,896 $65.82 p/Share	910 Reduced 1.49%	59,995 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	2,051 Added 3.26%	60,905 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$61,927 $65.95 p/Share	939 Reduced 1.57%	58,854 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	2,115 Added 3.42%	59,793 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	7,983 Reduced 12.16%	57,678 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	18,000 Added 21.52%	65,661 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$311,017 $57.81 p/Share	5,380 Reduced 10.14%	47,661 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	11,772 Added 18.16%	53,041 Common Stock
Dec 15 2023	SELL Open market or private sale	$649,079 $55.61 p/Share	11,672 Reduced 22.05%	41,269 Common Stock
Dec 15 2023	BUY Exercise of conversion of derivative security	$94,212 $14.7 p/Share	6,409 Added 10.8%	52,941 Common Stock
Nov 15 2023	SELL Open market or private sale	$632,218 $54.17 p/Share	11,671 Reduced 20.05%	46,532 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 9.92%	58,203 Common Stock

Also insider at

NVST

Envista Holdings Corp Healthcare

Director